In a 40-year-old man with a 20‑cm erythema migrans rash on his back, fatigue, headache, and mild chills after recent hiking, and no fever or joint pain, what is the most appropriate next step in management?

Treat Empirically with Doxycycline 100 mg Twice Daily for 10-14 Days

For this 40-year-old man with a 20-cm erythema migrans rash following hiking exposure, the most appropriate next step is to start empiric treatment with oral doxycycline immediately without waiting for serologic testing. 1, 2

Clinical Diagnosis Without Laboratory Testing

This patient has a classic presentation of early localized Lyme disease:

• Large erythema migrans lesion (20 cm diameter with central clearing)
• Recent woodland exposure (10 days ago in endemic area)
• Associated systemic symptoms (fatigue, headache, mild chills)
• No fever or joint pain (ruling out disseminated disease or coinfection)

Erythema migrans is the only manifestation of Lyme disease sufficiently distinctive to allow clinical diagnosis without laboratory confirmation. 1 Serologic testing is too insensitive in the acute phase (first 2 weeks) to be diagnostically helpful, with only 35% of patients showing positive antibody responses early in infection. 1, 2

Why Not Order Two-Tier Testing?

Ordering Borrelia serology now would:

• Delay necessary treatment while waiting for results
• Likely return false-negative results this early in infection
• Not change management since the clinical diagnosis is secure
• Waste resources unnecessarily

The 2021 IDSA/AAN/ACR guidelines explicitly recommend clinical diagnosis over laboratory testing when patients have compatible epidemiologic exposure and skin lesions consistent with erythema migrans. 2

Why Not Lumbar Puncture?

This patient has no neurologic manifestations requiring CSF analysis:

• No meningismus beyond mild headache
• No cranial nerve palsies
• No radiculoneuritis
• No altered mental status

Lumbar puncture is reserved for patients with specific neurologic complications like meningitis, cranial neuropathies, or radiculoneuritis—none of which are present here. 1

Why Not IV Ceftriaxone?

Intravenous ceftriaxone is indicated for:

• Neurologic Lyme disease (meningitis, encephalitis, radiculoneuritis)
• Advanced cardiac involvement (high-degree AV block)
• Late disseminated disease unresponsive to oral therapy

A prospective randomized trial of 180 patients demonstrated that adding a single 2-g IV dose of ceftriaxone to oral doxycycline provided no improvement in outcome but was associated with a 4-fold increase in diarrhea. 1 This patient's early localized disease responds excellently to oral antibiotics alone.

Recommended Treatment Regimen

Doxycycline 100 mg orally twice daily:

• Duration: 10 days minimum (acceptable range 10-21 days) 1, 2
• 14 days preferred for uniformity with other first-line agents 1

Advantages of Doxycycline

• Highly effective for erythema migrans (A-I evidence level) 1
• Covers coinfection with Anaplasma phagocytophilum (HGA), which can occur simultaneously in endemic areas 1
• Shorter treatment duration compared to beta-lactams (10 vs 14 days)
• Well-tolerated with proper administration

Administration Instructions

• Take with 8 ounces of fluid to reduce esophageal irritation
• Take with food to minimize GI intolerance
• Avoid sun exposure due to photosensitivity risk (important since Lyme disease occurs in summer months) 1

Alternative Regimens (If Doxycycline Contraindicated)

If this patient had contraindications to doxycycline (pregnancy, lactation, documented allergy):

• Amoxicillin 500 mg three times daily for 14 days, OR
• Cefuroxime axetil 500 mg twice daily for 14 days 1, 2

Macrolides (azithromycin, clarithromycin) are NOT recommended as first-line therapy due to inferior efficacy in clinical trials. 1

Expected Outcome

With prompt oral antibiotic treatment:

• Excellent prognosis with complete resolution expected 1, 3
• Most patients respond promptly and completely 1
• Less than 10% fail to respond to initial therapy 1
• Risk of late complications (arthritis, neurologic disease) is effectively eliminated 1

Common Pitfalls to Avoid

1. Don't wait for tick identification - Most patients with Lyme disease don't recall a tick bite 4
2. Don't delay treatment for serology - Early antibody responses are absent in 65% of cases 1, 3
3. Don't use first-generation cephalosporins (cephalexin) - They are ineffective for Lyme disease 1
4. Don't extend treatment beyond 14 days - Longer courses provide no additional benefit 1
5. Don't misinterpret Jarisch-Herxheimer reactions - Transient symptom worsening in first 24 hours is benign and self-limited 1

Monitoring for Coinfection

While treating, remain vigilant for signs suggesting coinfection with Anaplasma or Babesia:

• High fever persisting >48 hours despite appropriate antibiotics
• Unexplained leukopenia, thrombocytopenia, or anemia
• Worsening constitutional symptoms despite EM resolution 1

Doxycycline covers both Lyme disease and HGA, providing additional protection in this endemic exposure scenario. 1